https://www.selleckchem.com/products/ri-1.html
his remains the largest cohort of KTR from living donors who recovered from COVID-19. For mycophenolic acid (MPA), therapeutic drug monitoring (TDM) is an essential tool for dosage optimization in transplant recipients and autoimmune diseases. In China, a new commercial kit using an immunochromatographic assay (FICA) with a point-of-care testing (POCT) system was approved for TDM of MPA. However, corroboration between FICA and clinically used assays remains unknown. The authors evaluated MPA concentrations in heart transplant recipients ob
Like
Comment
Share
